Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

3 employees of Noida-based Marion Biotech arrested

Ruchika Sharma4 March 2023 12:30 PM IST

New Delhi: The Noida Police on Friday arrested three employees of a Noida-based pharmaceutical firm whose cough syrup is alleged to have led to the...

USFDA approves Zydus Lifesciences Infantile spasm drug Vigabatrin

Ruchika Sharma4 March 2023 11:10 AM IST

The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad.

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

USFDA accepts Bristol Myers Squibb sBLA for Opdivo for Resected Stage IIB/C Melanoma

Ruchika Sharma4 March 2023 10:00 AM IST

Melanoma is a form of skin cancer characterized by the uncontrolled growth of pigment-producing cells (melanocytes) located in the skin.

Bristol Myers Squibb wins dismissal of USD 6.4 billion lawsuit over cancer drug delay

Ruchika Sharma3 March 2023 2:30 PM IST

New York: A U.S. judge on Wednesday dismissed a lawsuit accusing Bristol Myers Squibb Co of defrauding investors who stood to receive $6.4 billion had...

Caplin Steriles bags USFDA nod for Rocuronium Bromide Injection

Ruchika Sharma3 March 2023 1:30 PM IST

Rocuronium Bromide Injection is a neuromuscular blocking agent, indicated as an adjunct to general anesthesia to facilitate both rapid sequence and...

CDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III Study

Information security incident occurred at Sun Pharma, impacted IT assets isolated

Ruchika Sharma3 March 2023 12:30 PM IST

New Delhi: Drug major Sun Pharma has reported an "information security incident" at the company and said it is investigating the matter. The...

Zydus Lifesciences cold sores cream Acyclovir bags USFDA okay

Ruchika Sharma3 March 2023 11:28 AM IST

The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad.

Bulk Drug Manufacturers Association to establish Technology and Training Center in Hyderabad

Ruchika Sharma3 March 2023 10:00 AM IST

The Technology center will act as a centralized location for high end research and testing.

Need to shift to profit model through enhancing RnD capacities in pharma sector, says Mansukh Mandaviya

Ruchika Sharma2 March 2023 5:15 PM IST

New Delhi: There is a need to shift to a profit model through enhancing research and development capabilities in the pharmaceutical sector, chemicals...

Pfizer Sells ViiV Stake for USD 1.9 Billion, Shionogi Emerges Bigger Partner

Pfizer, BioNTech submit application to USFDA for emergency use nod of Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years

Ruchika Sharma2 March 2023 4:15 PM IST

New York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use...

Janssen-Cilag Guselkumab receives UK nod for Crohns disease, ulcerative colitis

Janssen seeks USFDA nod for Niraparib and Abiraterone Acetate Dual-Action Tablet, plus Prednisone to treat patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Gene Mutations

Ruchika Sharma2 March 2023 3:15 PM IST

Metastatic castration-resistant prostate cancer characterizes cancer that no longer responds to androgen deprivation therapy and has spread to other...

Eli Lilly to cut insulin prices by 70 percent

Ruchika Sharma2 March 2023 2:15 PM IST

The company will lower the price of Humalog, its most commonly prescribed insulin, and Humulin, by 70 percent starting in the fourth quarter of this...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok